MYC and neoplasm: Though PD-L1 was present on tumor-associated immune cells in the MYC-driven TNBC model (Fig. 1g), the poor tumor response to anti-PD-L1 (Fig. 1a, b) led us to postulate that other factors might explain the observed immune evasion.